Placed on Senate Legislative Calendar under General Orders. Calendar No. 165.
The Royalty Transparency Act requires expanded financial-disclosure reporting for executive branch employees and specified advisory-committee members, specifically naming the original source and amount or value of royalties tied to inventions developed while employed by the federal government. It tasks the Government Accountability Office with identifying advisory committees making public-health recommendations, requires agencies to publish reports (including annual public lists of certain confidential filers who report royalties), mandates prompt congressional notification of ethics waivers, and directs procurement regulators to include royalty-payment reviews in contractor conflict-of-interest checks, with annual reporting to congressional committees.
Liberal emphasizes curbing industry influence; conservatives worry about privacy harms
Administrative ethics reform with bipartisan appeal, but privacy/science community objections and perceived targeting of public‑health advisory panels could slow floor support.
The Royalty Transparency Act requires expanded financial-disclosure reporting for executive branch employees and specified advisory-committee members, specifically naming the original source and amount or value of royalties tied to inventions developed while employed by the federal government.
It tasks the Government Accountability Office with identifying advisory committees making public-health recommendations, requires agencies to publish reports (including annual public lists of certain confidential filers who report royalties), mandates prompt congressional notification of ethics waivers, and directs procurement regulators to include royalty-payment reviews in contractor conflict-of-interest checks, with annual reporting to congressional committees.
The bill includes a 5-year adjustment to certain committee-listing provisions and a severability clause.
Narrow, oversight-focused bill with low fiscal cost improves odds, but privacy concerns, scientific community pushback, and Senate procedural barriers lower ultimate likelihood.
How solid the drafting looks.
Liberal emphasizes curbing industry influence; conservatives worry about privacy harms
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberal emphasizes curbing industry influence; conservatives worry about privacy harms
Likely to view the bill positively as increasing transparency and limiting improper private benefit from federally funded inventions.
It aligns with concerns about industry influence over public-health advisory processes and promotes public accountability.
However, liberals may worry about adequate privacy protections and effective enforcement.
Views the bill as a reasonable step to strengthen ethics and transparency while seeking balance with privacy and operational practicality.
Appreciates GAO oversight and procurement safeguards but wants clarity on administrative costs and intelligence or safety exemptions.
Support is conditional on measured implementation and minimal disruption to agency functions.
Likely skeptical of expanded disclosure and federal reporting mandates, seeing them as government overreach and a privacy risk for individuals.
Supports conflict-of-interest scrutiny but opposes public naming and numeric disclosure of royalties for confidential filers.
Worries about deterring private-sector collaboration and adding bureaucratic compliance burdens.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, oversight-focused bill with low fiscal cost improves odds, but privacy concerns, scientific community pushback, and Senate procedural barriers lower ultimate likelihood.
The bill has not accumulated any surfaced votes yet.
Liberal emphasizes curbing industry influence; conservatives worry about privacy harms
Narrow, oversight-focused bill with low fiscal cost improves odds, but privacy concerns, scientific community pushback, and Senate procedur…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Royalty Transparency Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.